BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30632048)

  • 1. In Vitro Interactions of Amphotericin B Combined with Non-antifungal Agents Against Rhodotorula mucilaginosa Strains.
    Spader TB; Ramírez-Castrillón M; Valente P; Alves SH; Severo LC
    Mycopathologia; 2019 Feb; 184(1):35-43. PubMed ID: 30632048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates.
    Nunes JM; Bizerra FC; Ferreira RC; Colombo AL
    Antimicrob Agents Chemother; 2013 Jan; 57(1):382-9. PubMed ID: 23114761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug susceptibility of 64 strains of Rhodotorula sp.
    Krzyściak P; Macura AB
    Wiad Parazytol; 2010; 56(2):167-70. PubMed ID: 20707302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital.
    Falces-Romero I; Cendejas-Bueno E; Romero-Gómez MP; García-Rodríguez J
    Mycoses; 2018 Jan; 61(1):35-39. PubMed ID: 28922488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular identification and antifungal susceptibility testing of Pucciniomycotina red yeast clinical isolates from Rio de Janeiro, Brazil.
    Brito-Santos F; Figueiredo-Carvalho MHG; Coelho RA; de Oliveira JCA; Monteiro RV; da Silva Chaves AL; Almeida-Paes R
    Braz J Microbiol; 2020 Mar; 51(1):95-98. PubMed ID: 31776863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism.
    Venturini TP; Al-Hatmi AMS; Rossato L; Azevedo MI; Keller JT; Weiblen C; Santurio JM; Alves SH
    Int J Antimicrob Agents; 2018 May; 51(5):784-788. PubMed ID: 29127050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
    Li H; Lu Q; Wan Z; Zhang J
    Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review.
    Gomez-Lopez A; Mellado E; Rodriguez-Tudela JL; Cuenca-Estrella M
    J Antimicrob Chemother; 2005 Mar; 55(3):312-6. PubMed ID: 15695538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence and antifungal therapy of murine disseminated infection by Rhodotorula mucilaginosa.
    Thomson P; López-Fernández L; Guarro J; Capilla J
    Diagn Microbiol Infect Dis; 2017 Sep; 89(1):47-51. PubMed ID: 28669678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Rhodotorula activity of mycophenolic acid enhanced in the presence of polyene antibiotic nystatin.
    Kinoshita H; Wongsuntornpoj S; Ihara F; Nihira T
    Lett Appl Microbiol; 2017 Feb; 64(2):144-149. PubMed ID: 27801509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodotorula fungemia: two cases and a brief review.
    Duggal S; Jain H; Tyagi A; Sharma A; Chugh TD
    Med Mycol; 2011 Nov; 49(8):879-82. PubMed ID: 21595509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synergistic effects of chlorpromazine and sertraline in combination with amphotericin B against Cryptococcus neoformans var. grubii.
    Rossato L; Loreto ÉS; Zanette RA; Chassot F; Santurio JM; Alves SH
    Folia Microbiol (Praha); 2016 Sep; 61(5):399-403. PubMed ID: 26847460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections.
    Iatta R; Immediato D; Montagna MT; Otranto D; Cafarchia C
    Med Mycol; 2015 Apr; 53(3):269-74. PubMed ID: 25631480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.
    Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH
    Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro synergistic effect of moxifloxacin and amphotericin B combination against Candida strains].
    Yalçin B; Kalkanci A; Gürelik F; Fidan I; Kustimur S; Ozdek S
    Mikrobiyol Bul; 2010 Jan; 44(1):65-70. PubMed ID: 20455400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula.
    Serena C; Mariné M; Pastor FJ; Nolard N; Guarro J
    J Antimicrob Chemother; 2005 Jun; 55(6):1020-3. PubMed ID: 15845779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species identification, antifungal susceptibility profiles and biofilm formation attributes of Rhodotorula isolates from ocular infections.
    Ahmed NH; Xess I; Singh G; Satpathy G; Sharma N; Agarwal T; Hussain T; Chawla R; Tandon R
    Mycoses; 2021 Oct; 64(10):1183-1196. PubMed ID: 34228832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Envelope Integrity and Capsule Characterization of Rhodotorula mucilaginosa Strains from Clinical and Environmental Sources.
    Yockey J; Andres L; Carson M; Ory JJ; Reese AJ
    mSphere; 2019 Jun; 4(3):. PubMed ID: 31167944
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of Amphotericin B Formulations and Voriconazole, Alone or in Combination, against Biofilms of
    Vikelouda K; Simitsopoulou M; Skoura L; Antachopoulos C; Roilides E
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0063821. PubMed ID: 34370583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.